CD4 and anemia (phenotype): The BD FACSPresto method is particularly valuable in this context as it facilitates the detection of anemia, which is an adverse effect associated with Zidovudine, a commonly used in resource-limited regions, and allows for CD4+ T lymphocyte monitoring within a single hospital visit.